GTC
ABBV icon

Ghost Tree Capital’s AbbVie ABBV Stock Holding History

Ghost Tree Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-70,000
Closed -$4.1M – 71
2015
Q1 		$4.1M Buy
+70,000
New +$4.23M 1.47% 29

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Ghost Tree Capital's ABBV Position: Q2 2015 in Review

Ghost Tree Capital sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 70,000 shares — an estimated $4.1M sold.

Ghost Tree Capital first reported a position in ABBV in Q1 2015 and held it in 1 quarter. The position peaked at $4.1M in Q1 2015. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • Ghost Tree Capital reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • Ghost Tree Capital sold 70,000 AbbVie shares in Q2 2015, an estimated $4.1M.
  • Ghost Tree Capital first reported a position in AbbVie in Q1 2015 and held it in 1 quarter.
  • Ghost Tree Capital's AbbVie position peaked at $4.1M in Q1 2015.
  • 1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Ghost Tree Capital's 13F filing for Q2 2015, filed 14 Aug 2015.